{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:44:45Z","timestamp":1792215885973,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10806"],"award-info":[{"award-number":["24K10806"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26K15681"],"award-info":[{"award-number":["26K15681"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.meddos.2026.09.001","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:55:23Z","timestamp":1792122923000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpretation of PlanIQ-derived feasibility dose\u2013volume histogram f-values in lung SBRT with heterogeneous dose distributions"],"prefix":"10.1016","author":[{"given":"Mayuka","family":"Kamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-0287","authenticated-orcid":false,"given":"Motoharu","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-4822","authenticated-orcid":false,"given":"Takeshi","family":"Kamomae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7960-8582","authenticated-orcid":false,"given":"Yuki","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Sakuragawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ikushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.meddos.2026.09.001_bib0001","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","article-title":"Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group study JCOG0403","volume":"93","author":"Nagata","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"issue":"11","key":"10.1016\/j.meddos.2026.09.001_bib0002","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"10185","key":"10.1016\/j.meddos.2026.09.001_bib0003","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.meddos.2026.09.001_bib0004","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3390\/cancers14153815","article-title":"Relationship between dose prescription methods and local control rate in stereotactic body radiotherapy for early stage non-small-cell lung cancer: Systematic review and meta-analysis","volume":"14","author":"Eriguchi","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.meddos.2026.09.001_bib0005","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/0284186X.2016.1273544","article-title":"Knowledge-based planning for stereotactic radiotherapy of peripheral early-stage lung cancer","volume":"56","author":"Delaney","year":"2017","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.meddos.2026.09.001_bib0006","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.prro.2013.04.001","article-title":"Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: Optimal isodose line fitting to the planning target volume","volume":"4","author":"Oku","year":"2014","journal-title":"Pract. Radiat. Oncol"},{"issue":"4","key":"10.1016\/j.meddos.2026.09.001_bib0007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.prro.2011.11.012","article-title":"Variation in external beam treatment plan quality: An inter-institutional study of planners and planning systems","volume":"2","author":"Nelms","year":"2012","journal-title":"Pract. Radiat. Oncol"},{"key":"10.1016\/j.meddos.2026.09.001_bib0008","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/acm2.12165","article-title":"Assessment of PlanIQ feasibility DVH for head and neck treatment planning","volume":"18","author":"Fried","year":"2017","journal-title":"J. Appl. Clin. Med. Phys"},{"key":"10.1016\/j.meddos.2026.09.001_bib0009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.rpor.2019.08.003","article-title":"Evaluation of plan quality improvements in PlanIQ-guided autoplanning","volume":"24","author":"Perumal","year":"2019","journal-title":"Rep. Pract. Oncol. Radiother"},{"key":"10.1016\/j.meddos.2026.09.001_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/acm2.12897","article-title":"Personalized setting of plan parameters using feasibility dose volume histogram for auto-planning in Pinnacle system","volume":"21","author":"Xia","year":"2020","journal-title":"J. Appl. Clin. Med. Phys"},{"issue":"4","key":"10.1016\/j.meddos.2026.09.001_bib0011","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.meddos.2021.03.013","article-title":"Impact of treatment planning quality assurance software on volumetric-modulated arc therapy plans for prostate cancer patients","volume":"46","author":"Sasaki","year":"2021","journal-title":"Med. Dosim"},{"issue":"4","key":"10.1016\/j.meddos.2026.09.001_bib0012","doi-asserted-by":"crossref","first-page":"462","DOI":"10.5603\/rpor.106490","article-title":"Linear accelerator selection: Impact on feasibility dose-volume histograms and practicality in dose reduction for organs at risk during prostate volumetric-modulated arc therapy","volume":"30","author":"Sasaki","year":"2025","journal-title":"Rep. Pract. Oncol. Radiother"},{"key":"10.1016\/j.meddos.2026.09.001_bib0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejmp.2021.04.021","article-title":"Lung dose reduction in patients with stage III non-small-cell lung cancer using software that estimates patient-specific dose reduction feasibility","volume":"85","author":"Shimizu","year":"2021","journal-title":"Phys. Med"},{"issue":"3","key":"10.1016\/j.meddos.2026.09.001_bib0014","first-page":"277","volume":"47","author":"Kimura","year":"2017","journal-title":"Jpn J. Clin. Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2026.09.001_bib0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.meddos.2025.09.007","article-title":"Ratio of PTV to normal lung volumes as a dosimetric predictor for lung metrics in peripheral lung SBRT","volume":"51","author":"Han","year":"2026","journal-title":"Med. Dosim"}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394726000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394726000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:24:30Z","timestamp":1792214670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394726000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":15,"alternative-id":["S0958394726000695"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2026.09.001","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpretation of PlanIQ-derived feasibility dose\u2013volume histogram f-values in lung SBRT with heterogeneous dose distributions","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2026.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}